4//SEC Filing
Sundaram Preethi 4
Accession 0001161697-24-000507
CIK 0001369568other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:00 PM ET
Size
9.2 KB
Accession
0001161697-24-000507
Insider Transaction Report
Form 4
Sundaram Preethi
Chief Strategy Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-12-09−6,855→ 701,766 total→ Common Stock (6,855 underlying) - Exercise/Conversion
Common Stock, par value $0.001 per share
2024-12-09+6,855→ 32,396 total - Tax Payment
Common Stock, par value $0.001 per share
2024-12-09−2,415→ 29,981 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F3]Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 9, 2024.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001872422
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:00 PM ET
- Size
- 9.2 KB